Pharma & Biotech
Gold & Silver
Crypto
Battery Metals
Artificial Intelligence
You will receive alerts when there are new announcements on Aurinia Pharmaceuticals
Only registered members can use this feature.
or
Aurinia is a late stage biopharmaceutical company focused on the development of its novel therapeutic immunomodulating drug candidate, voclosporin, for the treatment of lupus nephritis.
© Proactive Group Holdings, Inc. All Rights Reserved.
Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use.